FDA: New Depression Drug âNot Approvableâ
Gepirone, a new depression drug by Fabre-Kramer Pharmaceuticals, did not meet the FDAs efficacy standards. The new drug application for gepirone has now received...
The Crisis of Expertise
From Aeon: Experts have been wrong many times throughout history, from nutritional scientists' claims that eggs might be lethal in the 1970s to the Nobel...
Dr. Andrew Weil Says We’re Taking Too Many Medicines
From The New York Times: According to Dr. Andrew Weil, who is best known for popularizing the concept of integrative medicine, the problem of overmedication...
Disclosing Corporate Funding is Not Nearly Enough
From The Chronicle of Higher Education: A number of studies have shown the significant problems that arise from financial conflicts in research. Disclosure of researchers'...
Is Evidence Based Medicine a Form of Microfascism?
In this post for BMJ Opinion, Richard Smith critiques a 2006 paper condemning evidence based medicine as an exclusionary, colonizing form of microfascism that promotes a...
Does Marijuana Make for Depressed Brains?
From U.S. News & World Report: While some medical marijuana advocates claim that certain strands of weed may help with depression, research on the effects of...
Drug May Lead to Early Death for People With Alzheimer’s
From The Washington Post: A recent study found that benzodiazepines are associated with a greater chance of early death for those with Alzheimer's.
"Researchers analyzed data on...
âWhen Meth Was an Antidepressantâ
The Atlantic compares the use of meth as a âtop-line antidepressantâ in the 1930s to the 1950s to debates over the use of medicinal marijuana today. âItâs an example of how pharmaceuticals, at their core, are drugs. Theyâre chemicals that were mixed together and believed to be beneficial to humanity, until they weren't.â
Online Communities for Drug Withdrawal: What Can We Learn?
From Psychiatric Times: Patients are increasingly turning to the internet as a source of information and support for antidepressant and benzodiazepine withdrawal due to the psychiatric...
âThe Hidden Harms of Antidepressantsâ
In a new article for Scientific American, Diana Kwon reports on how the true risks for suicide and aggression in children and teens taking...
Lawsuit Over a Suicide Points to a Risk of Antidepressants
From The New York Times: The recent trial of Wendy Dolin, whose husband died of suicide after starting the antidepressant paroxetine, demonstrates our need for more...
âAnti-Smoking Drug Chantix Linked to Over 500 Suicides: Should It Retain Its FDA Approval?â
The FDA has received reports of over 544 suicides and 1,869 attempted suicides connected to the smoking cessation drug Chantix, according to a new...
The Epidemic of “Junk Science”
From The Lown Institute: Every year, we spend $240 billion to fund biomedical research. According to a science reporter and author Richard Harris, as much as half...
Experts ‘In Denial’ Over Withdrawal Harm From Prescription Pills
From The Herald: MSP (Member of the Scottish Parliament) Michelle Ballantyne has spoken out about the epidemic of withdrawal effects of prescription pills, critiquing physicians'...
First Federal Zoloft Birth Defect Trial Scheduled
In a bellwether case, plaintiffs allege that Pfizer did not adequately warn patients that Zoloft (sertraline) would cause birth defects. The case is scheduled in Federal Court in March, and the verdict will have significant implications for future suits.
âPsychiatric Drugs Are Being Prescribed to Infantsâ
The New York Times reports that a growing number of infants and toddlers are being prescribed dangerous psychiatric drugs. âAlmost 20,000 prescriptions for risperidone (commonly known as Risperdal), quetiapine (Seroquel) and other antipsychotic medications were written in 2014 for children 2 and younger, a 50 percent jump from 13,000 just one year before.â
The Virtual Couch: Is Online Therapy Going Viral?
From Alternet: Applications that provide online counseling, such as BetterHelp and Talkspace, are increasing in popularity. While some studies support the effectiveness of virtual therapy,...
The Trump Administration Isn’t Taking on Health Care Waste
From U.S. News: The Trump administration is not taking any actions to address the epidemic of waste, i.e. unnecessary tests and treatments, in the medical...
âHouse Passes Controversial Medical Funding ‘Cures’ Billâ
âDemocrats and consumer groups were upset with the bill's streamlining of some Food and Drug Administration processes, including making it easier for companies to...
Proove Biosciences Sells Off Assets as CEO Departs
From STAT: Proove Biosciences, which sold dubious DNA tests to predict opioid addiction risk, has been placed into court-ordered receivership for restructuring and asset sale. Experts...
Your Instagram Posts May Hold Clues to Your Mental Health
From The New York Times: New research suggests that Instagram users who have been diagnosed with depression tend to post darker, bluer, and grayer photos...
Off-Label Prescribing Increases Risk of Adverse Effects
The first systematic investigation of the adverse effects associated with prescribing drugs âoff-labelâ found that the common practice of using drugs for conditions for which they are not approved increases the risk of adverse effects.
âFrench Drug Trial had Three Major Failingsâ
The drug trial that led to the death of one participant and brain damage to several others last month had three major shortcomings, according...
âPeople with Psychiatric Disabilities: Our Modern-Day Scapegoatsâ
For the North Carolina Law Review, Katie Rose Guest Pryal writes, that â a psychiatric diagnosis, or involuntary civil commitment to a psychiatric wardâwhich is...
Cancer Drug Offers a Cautionary Tale of Deregulating the FDA
To illustrate the dangers of Trump's plans to deregulate the FDA, Susan Perry from MinnPost provides a cautionary tale about Tarceva, a drug approved by the...